What products do AstraZeneca sell?

Iressa® (gefitinib) GB / NI.

What common drugs does AstraZeneca make?

Help affording your medicines

• BEVESPI AEROSPHERE™ (glycopyrrolate and formoterol fumarate) inhalation aerosol.
• BREZTRI AEROSPHERE™ (budesonide, glycopyrrolate and formoterol fumarate) inhalation aerosol.
• BRILINTA® (ticagrelor) Tablets.
• BYDUREON® (exenatide extended-release) for injectable suspension.

What is AstraZeneca’s biggest drug?

As of 2020, AstraZeneca’s top pharmaceutical product by revenue was Tagrisso, a medication used in the treatment of non-small-cell lung carcinomas. During that year, Tagrisso generated nearly 4.3 billion U.S. dollars in revenue for the company.

Where is AstraZeneca vaccine made?

AstraZeneca’s COVID-19 vaccine manufactured in Thailand has been authorised under the World Health Organization (WHO) Emergency Use Listing (EUL) procedure, with immediate effect. In February 2021, the WHO granted EUL to AstraZeneca’s COVID-19 vaccine, enabling global access during the pandemic.

Which country made Covishield vaccine?

Covishield is the Indian-made version of AstraZeneca’s Vaxzevria jab, which has been authorised in the EU. The vaccines currently eligible for the green pass have all been approved by the European Medicines Agency (EMA).

How many countries does AstraZeneca operate in?

The company operates nine research and development sites and has sales in over 100 countries worldwide.

Is AstraZeneca better than Pfizer?

In terms of efficacy, the Pfizer vaccine protects 94.5% of people from developing COVID. The AstraZeneca shot protects 70% of people on average — still pretty good and on par with the protection given by a flu vaccine in a good year.

Does AstraZeneca have a pension?

AstraZeneca Defined Benefit Pension Plan is a single-employer defined benefit corporate pension fund based in Wilmington, Delaware. Established in 1976, the plan provides death, disability, and retirement benefits to the eligible employees of AstraZeneca.

Where is AstraZeneca home?

Wilmington, Delaware The headquarters of our North America Commercial Business is located in Wilmington, DE and is home to several business functions integral to the U.S. business.

Where is AstraZeneca listed on the stock market?

AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has secondary listings on Nasdaq OMX Stockholm, Nasdaq New York, the Bombay Stock Exchange and on the National Stock Exchange of India .

Is AstraZeneca’s tremelimumab approved in the US?

In April 2015, AstraZeneca’s drug tremelimumab was approved as an orphan drug for the treatment of mesothelioma in the United States. In February 2016, AstraZeneca announced that a clinical trial of tremelimumab as a treatment for mesothelioma failed to meet its primary endpoint.

What happened to AstraZeneca’s experimental drugs?

In February 2018, AstraZeneca announced it spinning off six early-stage experimental drugs into a new biotechnology focussed company, to be known as Viela Bio, valued at $250 million.

How many jobs has AstraZeneca cut in 2016?

AstraZeneca also announced that it would move its corporate headquarters from London to Cambridge in 2016. That announcement included the announcement that it would cut 1,600 jobs; three days later it announced it would cut an additional 2,300 jobs.